Emily Carter analyzes regulatory, policy, and governance issues influencing biotechnology and medical innovation. Her work examines how regulatory decisions, legal frameworks, and public policy shape research, commercialization, and patient access. At BioIntel, Emily brings a systems-level perspective, linking policy developments with scientific and market realities.